|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [S-Nitrosoglutathione results in increased expression of HIF1A protein]; 2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [TNF protein results in increased expression of HIF1A protein] |
CTD |
PMID:11514583 |
|
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
2,3-dimethoxy-1,4-naphthoquinone inhibits the reaction [TNF protein results in increased expression of HIF1A protein] |
CTD |
PMID:11514583 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TPO |
thyroid peroxidase |
decreases activity |
EXP |
2,3-dimethoxy-1,4-naphthoquinone results in decreased activity of TPO protein |
CTD |
PMID:11815678 |
|
NCBI chr 3:132,384,677...132,409,750
Ensembl chr 3:132,384,583...132,409,208
|
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions |
EXP |
7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein |
CTD |
PMID:11042205 |
|
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
|
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
multiple interactions increases uptake |
EXP |
Chlortetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; daidzein inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; epigallocatechin gallate inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Genistein inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; naringin inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline] |
CTD |
PMID:31287969 |
|
NCBI chr 5:52,020,303...52,133,132
Ensembl chr 5:52,049,443...52,129,730
|
|
|
G |
GJA1 |
gap junction protein alpha 1 |
decreases expression |
EXP |
Doxorubicin results in decreased expression of GJA1 protein |
CTD |
PMID:32877659 |
|
NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
increases activity increases expression |
EXP |
Doxorubicin results in increased activity of MMP1 protein Doxorubicin results in increased expression of MMP1 mRNA |
CTD |
PMID:19782292 |
|
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
|
|
G |
MMP14 |
matrix metallopeptidase 14 |
increases expression increases activity |
EXP |
Doxorubicin results in increased expression of MMP14 mRNA Doxorubicin results in increased activity of MMP14 protein |
CTD |
PMID:19782292 |
|
NCBI chr 7:76,174,502...76,185,931
Ensembl chr 7:76,172,971...76,185,928
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
increases expression increases activity |
EXP |
Doxorubicin results in increased expression of MMP2 mRNA Doxorubicin results in increased activity of MMP2 protein |
CTD |
PMID:19782292 |
|
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
increases expression increases activity |
EXP |
Doxorubicin results in increased expression of MMP9 mRNA Doxorubicin results in increased activity of MMP9 protein |
CTD |
PMID:19782292 |
|
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
|
|
G |
TNF |
tumor necrosis factor |
decreases expression |
EXP |
Doxorubicin results in decreased expression of TNF mRNA |
CTD |
PMID:15810080 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
TNNT2 |
troponin T2, cardiac type |
decreases expression |
EXP |
Doxorubicin results in decreased expression of TNNT2 protein |
CTD |
PMID:32877659 |
|
NCBI chr10:23,749,528...23,759,696
Ensembl chr10:23,749,335...23,763,396
|
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
increases uptake multiple interactions |
EXP |
SLCO1A2 protein results in increased uptake of Doxycycline Doxycycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Doxycycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] |
CTD |
PMID:31287969 |
|
NCBI chr 5:52,020,303...52,133,132
Ensembl chr 5:52,049,443...52,129,730
|
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
multiple interactions increases uptake |
EXP |
Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Chlortetracycline]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Oxytetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] SLCO1A2 protein results in increased uptake of Oxytetracycline |
CTD |
PMID:31287969 |
|
NCBI chr 5:52,020,303...52,133,132
Ensembl chr 5:52,049,443...52,129,730
|
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
increases uptake multiple interactions |
EXP |
SLCO1A2 protein results in increased uptake of Tetracycline Tetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of estrone sulfate]; Tetracycline inhibits the reaction [SLCO1A2 protein results in increased uptake of Taurocholic Acid] |
CTD |
PMID:31287969 |
|
NCBI chr 5:52,020,303...52,133,132
Ensembl chr 5:52,049,443...52,129,730
|
|